• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Standards for opioid use disorder care: An assessment of Nordic approaches.阿片类物质使用障碍护理标准:北欧方法评估
Nordisk Alkohol Nark. 2019 Jun;36(3):286-298. doi: 10.1177/1455072518815322. Epub 2019 Jan 27.
2
Principles for managing OUD related to chronic pain in the Nordic countries based on a structured assessment of current practice.基于对当前实践的结构化评估,北欧国家管理与慢性疼痛相关的 OUD 的原则。
Subst Abuse Treat Prev Policy. 2018 Jun 1;13(1):22. doi: 10.1186/s13011-018-0160-7.
3
Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries.北欧国家癌症发病率趋势。北欧五个癌症登记处的合作研究。
Acta Pathol Microbiol Immunol Scand Suppl. 1986;288:1-151.
4
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
5
Assessing the role of GPs in Nordic health care systems.评估全科医生在北欧医疗保健系统中的作用。
Leadersh Health Serv (Bradf Engl). 2016 May 3;29(2):122-35. doi: 10.1108/LHS-11-2015-0036.
6
Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes.北欧国家宫颈癌死亡率趋势:与有组织的筛查计划的关联。
Lancet. 1987 May 30;1(8544):1247-9. doi: 10.1016/s0140-6736(87)92695-x.
7
Alcohol-attributed disease burden in four Nordic countries: a comparison using the Global Burden of Disease, Injuries and Risk Factors 2013 study.四个北欧国家的酒精所致疾病负担:基于《2013年全球疾病、伤害及风险因素负担研究》的比较
Addiction. 2016 Oct;111(10):1806-13. doi: 10.1111/add.13430. Epub 2016 Jun 6.
8
Fatal poisoning in drug addicts in the Nordic countries in 2017.2017 年北欧国家吸毒者的致命中毒事件。
Forensic Sci Int. 2020 Aug;313:110343. doi: 10.1016/j.forsciint.2020.110343. Epub 2020 May 20.
9
Developments in oral health policy in the Nordic countries since 1990.自1990年以来北欧国家口腔健康政策的发展。
Oral Health Prev Dent. 2005;3(4):225-35.
10
Antibiotic resistance among major pathogens compared to hospital treatment guidelines and antibiotic use in Nordic hospitals 2010-2018.2010-2018 年北欧医院主要病原体的抗生素耐药性与医院治疗指南和抗生素使用情况比较。
Infect Dis (Lond). 2021 Aug;53(8):607-618. doi: 10.1080/23744235.2021.1910338. Epub 2021 May 10.

引用本文的文献

1
"In Sweden you are worthless. In Denmark you get an identity again" - on being perceived and received as a person who uses drugs in different drug policy settings.“在瑞典你一文不值。在丹麦,你又有了身份”——在不同的毒品政策环境中,作为一名吸毒者,被感知和被接纳的感受。
Harm Reduct J. 2024 Jun 17;21(1):117. doi: 10.1186/s12954-024-01035-5.
2
Reasons for not entering opioid agonist treatment: A survey among high-risk opioid users in Finland.未接受阿片类激动剂治疗的原因:芬兰高危阿片类药物使用者的一项调查。
Nordisk Alkohol Nark. 2024 Apr;41(2):200-211. doi: 10.1177/14550725231204723. Epub 2023 Oct 17.
3
Long-acting injectable depot buprenorphine from a harm reduction perspective in patients with ongoing substance use and multiple psychiatric comorbidities: a qualitative interview study.从减少伤害的角度来看,对于正在使用物质且伴有多种精神共病的患者,长效注射型丁丙诺啡:一项定性访谈研究。
Harm Reduct J. 2024 Mar 25;21(1):68. doi: 10.1186/s12954-024-00984-1.
4
Patient perspectives on depot buprenorphine treatment for opioid addiction - a qualitative interview study.患者对阿片类药物成瘾的长效丁丙诺啡治疗的看法——一项定性访谈研究。
Subst Abuse Treat Prev Policy. 2022 May 25;17(1):40. doi: 10.1186/s13011-022-00474-2.
5
Predicting the Onset of Opioid Use Disorder in the Swedish General Population.预测瑞典普通人群中阿片类使用障碍的发病。
J Stud Alcohol Drugs. 2022 May;83(3):332-341. doi: 10.15288/jsad.2022.83.332.
6
Real-world effectiveness of pharmacological treatments of opioid use disorder in a national cohort.真实世界中全国队列中阿片类药物使用障碍的药物治疗效果。
Addiction. 2022 Jun;117(6):1683-1691. doi: 10.1111/add.15814. Epub 2022 Feb 7.
7
The "black box" of treatment: Patients' perspective on what works in opioid maintenance treatment for opioid dependence.治疗的“黑箱”:患者对阿片类药物维持治疗治疗阿片类药物依赖的有效性的看法。
Subst Abuse Treat Prev Policy. 2021 May 10;16(1):41. doi: 10.1186/s13011-021-00378-7.

本文引用的文献

1
Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus.阿片类物质使用障碍中丁丙诺啡和美沙酮治疗的建议:一项欧洲共识
Expert Opin Pharmacother. 2017 Dec;18(18):1987-1999. doi: 10.1080/14656566.2017.1409722. Epub 2017 Dec 3.
2
The societal cost of heroin use disorder in the United States.美国海洛因使用障碍的社会成本。
PLoS One. 2017 May 30;12(5):e0177323. doi: 10.1371/journal.pone.0177323. eCollection 2017.
3
The Story of Developing Needle Exchange Services in Iceland.
J Addict Nurs. 2016 Jul-Sep;27(3):157-9. doi: 10.1097/JAN.0000000000000131.
4
Opioid agonist treatment for pharmaceutical opioid dependent people.用于药物性阿片类物质依赖者的阿片类激动剂治疗
Cochrane Database Syst Rev. 2016 May 9(5):CD011117. doi: 10.1002/14651858.CD011117.pub2.
5
Opioid dependency rehabilitation with the opioid maintenance treatment programme - a qualitative study from the clients' perspective.从客户角度看阿片类药物维持治疗方案的阿片类药物依赖康复——一项定性研究
Subst Abuse Treat Prev Policy. 2015 Sep 15;10:35. doi: 10.1186/s13011-015-0031-4.
6
Income Generation in Recovering Heroin Users: A Comparative Analysis of Legal and Illegal Earnings.康复期海洛因使用者的收入来源:合法与非法收入的比较分析
J Offender Rehabil. 2015;54(5):338-349. doi: 10.1080/10509674.2015.1043479.
7
Family and social aspects of substance use disorders and treatment.物质使用障碍及治疗的家庭和社会层面
J Food Drug Anal. 2013 Dec;21(4):S73-S76. doi: 10.1016/j.jfda.2013.09.038.
8
Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings.针具和注射器方案以及阿片类物质替代疗法能否显著降低丙型肝炎病毒流行率?不同流行环境下的模型预测。
Addiction. 2012 Nov;107(11):1984-95. doi: 10.1111/j.1360-0443.2012.03932.x. Epub 2012 Jul 12.
9
Drug policy and the public good: evidence for effective interventions.药物政策与公共利益:有效干预措施的证据。
Lancet. 2012 Jan 7;379(9810):71-83. doi: 10.1016/S0140-6736(11)61674-7.
10
Cost-effectiveness of hepatitis C virus antiviral treatment for injection drug user populations.注射吸毒人群丙型肝炎病毒抗病毒治疗的成本效益分析。
Hepatology. 2012 Jan;55(1):49-57. doi: 10.1002/hep.24656. Epub 2011 Dec 6.

阿片类物质使用障碍护理标准:北欧方法评估

Standards for opioid use disorder care: An assessment of Nordic approaches.

作者信息

Gedeon Charlotte, Sandell Mikael, Birkemose Inge, Kakko Johan, Rúnarsdóttir Valgerður, Simojoki Kaarlo, Clausen Thomas, Nyberg Fred, Littlewood Richard, Alho Hannu

机构信息

Solstenen Addiction Centre, Skåne, Sweden.

Capio Maria, Stockholm and Skåne, Sweden.

出版信息

Nordisk Alkohol Nark. 2019 Jun;36(3):286-298. doi: 10.1177/1455072518815322. Epub 2019 Jan 27.

DOI:10.1177/1455072518815322
PMID:32934565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7434162/
Abstract

AIMS

Outcomes in opioid use disorder (OUD) in Nordic countries have improved with integrated treatment and harm-reduction programmes. Approaches and the standard of care are different across the region. Evidence of treatment needs and current approaches are defined from evidence to inform development of a common standard.

METHOD

Evidence of population sizes and treatment approach collected. Common standards for care (harm reduction, pharmacotherapy, psychology/social therapy) defined for each country.

RESULTS

Evidence defines number in treatment; potential population needing treatment not defined for all countries. Populations sizes, treatment access (ratio in treatment programme compared to total country population) defined: Sweden 4,000 in OUD care (access ratio 40); Finland 3,000 (55); Norway 8,000 (154); Denmark 7,500 (132). Approach to treatment similar: integrated treatment programmes standard. Care provided by specialists in outpatient clinics/primary care; secondary care/inpatient services are available. Harm reduction is limited in Sweden but available and more accessible elsewhere. Treatment entry criteria: access relatively unlimited in Norway and Denmark, more limited in Finland and Sweden. Standards of care defined: easy access to high-quality services, individual planning, care not limited by time, management of relapse, education for patients, continuous engagement, holistic approach including management of comorbidities, needle equipment programmes without limit, treatment in prisons as community.

CONCLUSION

There are opportunities to improve OUD care in the Nordics. Policy makers and clinicians can advance OUD care and share common success factors. Collaborative work across the Nordic countries is valuable. Further research in clinical practice development can yield important results for the benefit of patients with OUD.

摘要

目的

北欧国家通过综合治疗和减少伤害计划,阿片类物质使用障碍(OUD)的治疗效果有所改善。该地区的治疗方法和护理标准各不相同。确定治疗需求和当前方法的证据,以便为制定通用标准提供依据。

方法

收集人口规模和治疗方法的证据。为每个国家定义护理通用标准(减少伤害、药物治疗、心理/社会治疗)。

结果

证据确定了接受治疗的人数;并非所有国家都确定了需要治疗的潜在人群。确定了人口规模、治疗可及性(治疗项目中的人数与国家总人口的比例):瑞典有4000人接受OUD护理(可及性比例为40);芬兰有3000人(55);挪威有8000人(154);丹麦有7500人(132)。治疗方法相似:综合治疗项目为标准。由门诊诊所/初级保健的专科医生提供护理;提供二级护理/住院服务。瑞典的减少伤害措施有限,但在其他地方可用且更容易获得。治疗准入标准:挪威和丹麦的准入相对不受限制,芬兰和瑞典则更有限。确定的护理标准:易于获得高质量服务、个性化规划、护理不受时间限制、复发管理、患者教育、持续参与、包括合并症管理的整体方法、无限制的针头设备项目、在监狱中作为社区进行治疗。

结论

北欧地区有改善OUD护理的机会。政策制定者和临床医生可以推进OUD护理并分享共同的成功因素。北欧国家之间的合作工作很有价值。临床实践发展方面的进一步研究可为OUD患者带来重要成果。